Unlocking the TCR repertoire for personalized cancer immunotherapies. University of Antwerp
Center for Oncological Research (CORE), Laboratory for Experimental Hematology (LEH), ADReM Data Lab (ADReM)
Cancer is one of the leading causes of death worldwide. Over the past decades, new therapies have been developed that target the patients' immune system to mount an antitumor response. The efficacy of these immunotherapies has already been demonstrated in various clinical trials. Nevertheless, these therapies show a large variation in their individual responses as some patients respond well to the therapy, while others do not. In this project, ...